Al Ruzzeh S, Schmidt I, Nakamura K, Chester A, Ilsley C, & Amrani M (2004). Cerivastatin does not prevent oxidative injury of human aortic endothelial cells. Tex Heart Inst J31, 127-131.

Banner NR, Rose ML, Cummins D, de Silva M, Pottle A, Lyster H, Doyle P, Carby M, & Khaghani A (2004). Management of an ABO-incompatible lung transplant. Am J Transplant4, 1192-1196.

Banner NR & Yacoub MH (2004). Cyclosporine in thoracic organ transplantation. Transplant Proc36, 302S-308S.

Barber LD, Whitelegg A, Madrigal JA, Banner NR, & Rose ML (2004). Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation77, 1604-1609.

Barton PJ, Felkin LE, Koban MU, Cullen ME, Brand NJ, & Dhoot GK (2004). The slow skeletal muscle troponin T gene is expressed in developing and diseased human heart. Mol Cell Biochem263, 91-97.

Belvisi MG & Geppetti P (2004). Cough. 7: Current and future drugs for the treatment of chronic cough. Thorax59, 438-440.

Belvisi MG, Hele DJ, & Birrell MA (2004). New advances and potential therapies for the treatment of asthma. BioDrugs18, 211-223.

Belvisi MG, Hele DJ, & Birrell MA (2004). New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease. Expert Opin Ther Targets8, 265-285.

Birks EJ, Yacoub MH, Anyanwu A, Smith RR, Banner NR, & Khaghani A (2004). Transplantation using hearts from primary pulmonary hypertensive donors for recipients with a high pulmonary vascular resistance. J Heart Lung Transplant23, 1339-1344.

Birks EJ, Yacoub MH, Banner NR, & Khaghani A (2004). The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol19, 148-153.

Birks EJ, Tansley PD, Yacoub MH, Bowles CT, Hipkin M, Hardy J, Banner NR, & Khaghani A (2004). Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant23, 964-969.

Birks EJ, Felkin LE, Banner NR, Khaghani A, Barton PJ, & Yacoub MH (2004). Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices. J Heart Lung Transplant23, 228-235.

Birrell BA, Patel HJ, McCluskie K, Wong S, Leonard T, Yacoub MH, & Belvisi MG (2004). PPAR-gamma agonists as therapy for diseases involving airway neutrophilia. Eur Respir J24, 18-23.

Borozdenkova S, Westbrook JA, Patel V, Wait R, Bolad I, Burke MM, Bell AD, Banner NR, Dunn MJ, & Rose ML (2004). Use of proteomics to discover novel markers of cardiac allograft rejection. J Proteome Res3, 282-288.

Bowen IM, Marr CM, Chester AH, Wheeler-Jones CP, & Elliott J (2004). In-vitro contraction of the equine aortic valve. J Heart Valve Dis13, 593-599.

Brealey D, Karyampudi S, Jacques TS, Novelli M, Stidwill R, Taylor V, Smolenski RT, & Singer M (2004). Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol286, R491-R497.

Carrey EA, Smolenski RT, Edbury SM, Laurence A, Marinaki AM, Duley JA, Zhu LM, Goldsmith DJ, & Simmonds HA (2004). An unusual pyridine nucleotide accumulating in erythrocytes: its identity and positive correlation with degree of renal failure. Nucleosides Nucleotides Nucleic Acids23, 1135-1139.

Clarke D, Belvisi MG, Hardaker E, Newton R, & Giembycz MA (2004). E-Ring 8-Isoprostanes are Agonists at EP2- and EP4-Prostanoid Receptors on Human Airways Smooth Muscle Cells and Regulate the Release of Colony-stimulating Factors by Activating cAMP-dependent Protein Kinase. Mol Pharmacol.

Clarke DL, Belvisi MG, Catley MC, Yacoub MH, Newton R, & Giembycz MA (2004). Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF. Br J Pharmacol141, 1141-1150.

Clarke DL, Giembycz MA, Patel HJ, & Belvisi MG (2004). E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype. Br J Pharmacol141, 600-609.

Cullen ME, Dellow KA, & Barton PJ (2004). Structure and regulation of human troponin genes. Mol Cell Biochem263, 81-90.

De Souza AI, McGregor E, Dunn MJ, & Rose ML (2004). Preparation of human heart for laser microdissection and proteomics. Proteomics4, 578-586.

Gensini GF, Yacoub MH, & Conti AA (2004). The concept of quarantine in history: from plague to SARS. J Infect49, 257-261.

Giusti B, Marcucci R, Lapini I, Sestini I, Lenti M, Yacoub M, & Pepe G (2004). Role of hyperhomocysteinemia in aortic disease. Cell Mol Biol (Noisy -le-grand)50, 945-952.

Goldsmith D, Carrey EA, Edbury S, Smolenski RT, Jagodzinski P, & Simmonds HA (2004). Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients. Clin Sci (Lond)107, 63-68.

Hafizi S, Mordi VN, Andersson KM, Chester AH, & Yacoub MH (2004). Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. Vascul Pharmacol41, 167-176.

Hafizi S, Chester AH, & Yacoub MH (2004). Differential response of human cardiac fibroblasts to angiotensin I and angiotensin II. Peptides25, 1031-1033.

Hafizi S, Wang X, Chester AH, Yacoub MH, & Proud CG (2004). ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Am J Physiol Heart Circ Physiol287, H1232-H1238.

Hafizi S, Wharton J, Chester AH, & Yacoub MH (2004). Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts. Cell Physiol Biochem14, 285-292.

Jagodzinski P, Lizakowski S, Smolenski RT, Slominska EM, Goldsmith D, Simmonds HA, & Rutkowski B (2004). Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes. Clin Sci (Lond)107, 69-74.

Kershaw JD, Misfeld M, Sievers HH, Yacoub MH, & Chester AH (2004). Specific regional and directional contractile responses of aortic cusp tissue. J Heart Valve Dis13, 798-803.

Lango R, Pawlaczyk R, Raszeja-Specht A, Smolenski RT, Rogowski J, Rutkowski B, & Szutowicz A (2004). Aortic valve replacement and perioperative management in hemodialyzed patient wth antiphospholipid syndrome. Int J Artif Organs27, 69-73.

Lavitrano M, Smolenski RT, Musumeci A, Maccherini M, Slominska E, Di Florio E, Bracco A, Mancini A, Stassi G, Patti M, Giovannoni R, Froio A, Simeone F, Forni M, Bacci ML, D'Alise G, Cozzi E, Otterbein LE, Yacoub MH, Bach FH, & Calise F (2004). Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J18, 1093-1095.

Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, & Yacoub MH (2004). Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. European Heart Journal25, 587-610.

Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, & Yacoub MH (2004). Guidelines on the Diagnosis and Management of Pericardial Diseases. Executive Summary. Rev Esp Cardiol57, 1090-1114.

Mangoush O, Athanasiou T, Chester A, Lawrence D, & Amrani M (2004). The role of arterial grafts in coronary artery bypass grafting: an update. Heart Surg Forum7, E450-E453.

Mangoush O, Bahrami T, De Robertis F, Swinburn J, Banner N, Yacoub MH, & Khaghani A (2004). Regurgitation of the native aortic valve caused by thrombus formation after heterotopic heart transplantation. Ann Thorac Surg78, 1821-1823.

McCluskie K, Birrell MA, Wong S, & Belvisi MG (2004). Nitric oxide as a noninvasive biomarker of lipopolysaccharide-induced airway inflammation: possible role in lung neutrophilia. J Pharmacol Exp Ther311, 625-633.

Melina G, De Robertis F, Gaer JA, Amrani M, Khaghani A, & Yacoub MH (2004). Mid-term pattern of survival, hemodynamic performance and rate of complications after medtronic freestyle versus homograft full aortic root replacement: results from a prospective randomized trial. J Heart Valve Dis13, 972-975.

Mikhail GW, Prasad SK, Li W, Rogers P, Chester AH, Bayne S, Stephens D, Khan M, Gibbs JS, Evans TW, Mitchell A, Yacoub MH, & Gatzoulis MA (2004). Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. European Heart Journal25, 431-436.

Morice AH, Fontana GA, Sovijarvi AR, Pistolesi M, Chung KF, Widdicombe J, O'Connell F, Geppetti P, Gronke L, De Jongste J, Belvisi M, Dicpinigaitis P, Fischer A, McGarvey L, Fokkens WJ, & Kastelik J (2004). The diagnosis and management of chronic cough. Eur Respir J24, 481-492.

Murtuza B, Suzuki K, Bou-Gharios G, Beauchamp JR, Smolenski RT, Partridge TA, & Yacoub MH (2004). Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A101, 4216-4221.

O'Rourke B, Barbir M, Mitchell AG, Yacoub MH, & Banner NR (2004). Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation: results of a randomised double blind placebo controlled study. Int J Cardiol94, 235-240.

Rose ML (2004). De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system. J Heart Lung Transplant23, 385-395.

Rose ML (2004). Long-term effects of damage to the endothelium and chronic rejection. J Heart Lung Transplant23, S240-S243.

Rutkowski B, Swierczynski J, Slominska E, Szolkiewicz M, Smolenski RT, Marlewski M, Butto B, & Rutkowski P (2004). Disturbances of purine nucleotide metabolism in uremia. Semin Nephrol24, 479-483.

Sanchez-Feutrie M, Santalucia T, Fandos C, Noe V, Vinals F, Brand NJ, Ciudad CJ, Palacin M, & Zorzano A (2004). A novel muscle DNA-binding activity in the GLUT1 promoter. Cell Mol Life Sci61, 709-720.

Sato M, Gong H, Terracciano CM, Ranu H, & Harding SE (2004). Loss of beta-adrenoceptor response in myocytes overexpressing the Na+/Ca(2+)-exchanger. J Mol Cell Cardiol36, 43-48.

Slominska EM, Rutkowski P, Smolenski RT, Szutowicz A, Rutkowski B, & Swierczynski J (2004). The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma. Mol Cell Biochem267, 25-30.

Soppa GK, Smolenski RT, Latif N, Yuen AH, Malik AH, Karbowska J, Kochan Z, Terracciano CM, & Yacoub MH (2004). Effects of Chronic Administration of Clenbuterol on Function and Metabolism of Adult Rat Cardiac Muscle. Am J Physiol Heart Circ Physiol.

Stagg MA, Malik AH, MacLeod KT, & Terracciano CM (2004). The effects of overexpression of the Na+/Ca2+ exchanger on calcium regulation in hypertrophied mouse cardiac myocytes. Cell Calcium36, 111-118.

Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, & Yacoub MH (2004). Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J18, 1153-1155.

Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJ, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, & Yacoub MH (2004). Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation110, II219-II224.

Suzuki K, Murtuza B, Brand NJ, Varela-Carver A, Fukushima S, & Yacoub MH (2004). Enhanced effect of myocardial gene transfection by VP22-mediated intercellular protein transport. J Mol Cell Cardiol36, 603-606.

Suzuki K, Murtuza B, Smolenski RT, & Yacoub MH (2004). Selective cell dissemination into the heart by retrograde intracoronary infusion in the rat. Transplantation77, 757-759.

Suzuki K, Murtuza B, Fukushima S, Smolenski RT, Varela-Carver A, Coppen SR, & Yacoub MH (2004). Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation110, II225-II230.

Taegtmeyer AB, Crook AM, Barton PJ, & Banner NR (2004). Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: evidence that excision of the native heart contributes to post-transplant hypertension. J Am Coll Cardiol44, 1254-1260.

Tansley P, Yacoub M, Rimoldi O, Birks E, Hardy J, Hipkin M, Bowles C, Kindler H, Dutka D, & Camici PG (2004). Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy. J Heart Lung Transplant23, 1283-1289.

Tay SS, McCormack A, & Rose ML (2004). Effect of cognate human CD4+ T cell and endothelial cell interactions upon chemokine production. Transplantation78, 987-994.

Terracciano CM, Hardy J, Birks EJ, Khaghani A, Banner NR, & Yacoub MH (2004). Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation109, 2263-2265.

Yacoub MH & Cohn LH (2004). Novel approaches to cardiac valve repair: from structure to function: Part I. Circulation109, 942-950.

Yacoub MH & Cohn LH (2004). Novel approaches to cardiac valve repair: from structure to function: Part II. Circulation109, 1064-1072.

Yacoub MH, Yuen AH, Kalsi KK, Birks EJ, Taegtmeyer A, Barton PJ, Johnson PH, Suzuki K, & Smolenski RT (2004). C34T AMP deaminase 1 gene mutation protects cardiac function in donors. Transplantation77, 1621-1623.

Yacoub MH (2004). Professor Sir Magdi Habib Yacoub, FRS, FRCS, FRCP, DS: a conversation with the editor. Interview by William Clifford Roberts. Am J Cardiol93, 176-192.